Skip to main content
. Author manuscript; available in PMC: 2011 Nov 1.
Published in final edited form as: Am J Prev Med. 2010 Nov;39(5):e21–e29. doi: 10.1016/j.amepre.2010.07.014

TABLE 2.

Results from 90-day vaccination scenarios with no prioritization of ACIP groups

Attack rate by age group (years)
Total attack
rate (%)
≤ 4
(%)
5–18
(%)
19–24
(%)
25–49
(%)
50–64
(%)
≥ 65
(%)
Increasing-viral-transmissibility
scenarios
No vaccination 24.9 39.0 44.0 26.0 19.0 16.0 14.0
Vaccination initiated:
     8 weeks before peak 3.0 5.0 6.0 3.0 2.0 2.0 1.0
     4 weeks before peak 9.2 15.0 19.0 9.0 6.0 5.0 5.0
     At peak 15.3 25.0 30.0 15.0 11.0 9.0 8.0
Loss-of-cross-protection scenarios
No vaccination 26.7 43.0 51.0 26.0 19.0 16.0 14.0
Vaccination initiated:
     8 weeks before peak 7.5 12.0 16.0 7.0 5.0 4.0 4.0
     4 weeks before peak 13.0 21.0 27.0 12.0 9.0 7.0 6.0
     At peak 20.7 34.0 41.0 20.0 14.0 12.0 10.0
Change-in-social-mixing scenarios
No vaccination 26.7 22.0 24.0 14.0 10.0 8.0 7.0
Vaccination initiated:
     8 weeks before peak 2.6 4.0 5.0 2.0 2.0 1.0 1.0
     4 weeks before peak 6.0 10.0 11.0 6.0 4.0 4.0 3.0
     At peak 7.2 12.0 12.0 8.0 5.0 5.0 4.0
a

SEs for all attack rates were < 1%.